Search - tctmd.com

Displaying 281 - 300 of 406

Sort: Relevancy | Date

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Yael L. Maxwell

February 28, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Todd Neale

February 01, 2019

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Daily News

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

Todd Neale

October 02, 2018

Presentation TCT Abstracts Posters 2018

Cardiogenic Shock in a 58 Year Old Male with Critical 3 Vessel Disease: Intra-Aortic Balloon Pump (IABP) Stabilizing Hemodynamics to Facilitate Percutaneous Coronary Revascularization

Presenter: Conor Mcquillan

September 25, 2018

Presentation TCT 2018

How to Use Invasive Physiology in Assessing and Treating Left Main Disease

Presenter: Anibal A. Damonte, Jacques Monsegu, Leandro I Lasave

September 24, 2018

Presentation TCT 2018

Multivessel Disease: Should Invasive Physiology Change My Strategy?

Presenter: Anibal A. Damonte, Jacques Monsegu, Eric Van Belle

September 24, 2018

News Conference News TCT 2018

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Yael L. Maxwell

September 23, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

Advertisement

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

One in Two Americans Have Cardiovascular Disease: AHA Stats

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

TCTMD’s Top 10 Most Popular Stories for September 2018

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

Cardiogenic Shock in a 58 Year Old Male with Critical 3 Vessel Disease: Intra-Aortic Balloon Pump (IABP) Stabilizing Hemodynamics to Facilitate Percutaneous Coronary Revascularization

How to Use Invasive Physiology in Assessing and Treating Left Main Disease

Multivessel Disease: Should Invasive Physiology Change My Strategy?

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content